Latest DEF 14A proxy statements

Aptevo Therapeutics Inc. is holding a special meeting on September 22, 2026, to vote on critical proposals including charter amendments, stock and warrant issuances, and an updated stock incentive plan.

FingerMotion is holding a special meeting on October 6, 2026, to seek shareholder approval for issuing up to 19.99% of its stock to an institutional investor and increasing authorized shares.

GEE Group Inc. is convening its 2026 Annual Meeting of Shareholders virtually on September 24, 2026, to vote on key proposals including a 1-for-30 reverse stock split and a significant increase in authorized shares.

Spark I Acquisition Corporation is seeking shareholder approval to extend its deadline for completing a business combination with ZincFive, Inc. from September 29, 2026, to March 29, 2027.

Envoy Medical is holding a special meeting on October 12, 2026, to vote on a reverse stock split proposal aimed at regaining compliance with Nasdaq's minimum bid price requirement.

Catheter Precision, Inc. has issued a proxy statement detailing proposals for its upcoming Annual Meeting of Stockholders, including director elections, reincorporation, and equity plan amendments.

Bone Biologics Corporation has rescheduled its Annual Meeting of Stockholders to September 28, 2026, adding proposals for warrant share issuance approval and a reverse stock split.

NN, Inc. is holding a special meeting on September 30, 2026, to vote on several amendments to its Certificate of Incorporation, including a significant increase in authorized common stock.

Profusa, Inc. is holding a special meeting of stockholders on September 18, 2026, to vote on a proposal to approve an amendment to its Certificate of Incorporation to effect one or more reverse stock splits.

National Beverage Corp. has announced its Annual Meeting of Shareholders, scheduled for October 2, 2026, to elect a director and vote on executive compensation.

MillerKnoll announces its 2026 Annual Meeting of Shareholders, detailing proposals for director elections, executive compensation, and the 2026 Long-Term Incentive Plan, alongside fiscal 2026 financial highlights.

Immersion Corporation has announced its 2026 Annual Meeting of Stockholders, scheduled for October 7, 2026, to elect directors, ratify auditors, and vote on executive compensation.

Champions Oncology, Inc. has announced its Annual Meeting of Stockholders scheduled for October 14, 2026, with key proposals including the election of directors and the approval of the 2026 Equity Incentive Plan.

The Korea Fund, Inc. has issued its definitive proxy statement for the Annual Meeting of Stockholders on October 21, 2026, seeking shareholder approval for the re-election of Class II Director Matthew Sippel.

Procter & Gamble announces its 2026 Annual Meeting of Shareholders, detailing director nominees, executive compensation, and shareholder proposals.

Frequency Electronics, Inc. has issued its proxy statement for the upcoming Annual Meeting of Stockholders on October 7, 2026, detailing proposals for director elections, auditor ratification, and executive compensation.

Belpointe PREP, LLC has issued a proxy statement detailing its upcoming annual meeting on October 12, 2026, including proposals for director elections, auditor ratification, and a significant $250 million at-the-market public offering.

Singularity Future Technology Ltd. has announced a special meeting of stockholders on September 22, 2026, to vote on several key proposals, including a potential reverse stock split, a name change, and the issuance of new shares and warrants.

U.S. Gold Corp. has announced its Annual Meeting of Stockholders to be held virtually on October 13, 2026, with key proposals including the election of directors and ratification of its independent auditor.

Citius Oncology, Inc. has issued a proxy statement detailing the agenda for its 2026 Annual Meeting of Stockholders, including the election of directors and ratification of auditors.

374Water Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for September 18, 2026, as a virtual-only event, and is proposing several key corporate governance changes including a significant reduction in authorized shares.

WinVest Acquisition Corp. is holding a special meeting of stockholders to vote on proposals to extend the deadline for completing an initial business combination and to amend its trust agreement.

Credo Technology Group Holding Ltd announces its 2026 Annual General Meeting, detailing director elections, executive compensation, and auditor ratification, alongside strong fiscal 2026 financial performance.

RPM International Inc. has issued its 2026 Proxy Statement, detailing the upcoming Annual Meeting of Stockholders on October 8, 2026, and outlining key proposals including director elections and executive compensation.

Bexil Investment Trust is holding a special meeting on October 8, 2026, to vote on reclassifying its investment objective and re-approving its non-diversified status to enhance flexibility.

Silexion Therapeutics Corp is holding an extraordinary general meeting on September 9, 2026, to seek shareholder approval for a substantial increase in authorized share capital and a reverse stock split, aimed at maintaining Nasdaq listing compliance.

Quince Therapeutics, Inc. is holding a Special Meeting of Stockholders on October 6, 2026, to vote on several proposals, including the issuance of shares related to its recent acquisition of Orphai Therapeutics and a private placement.

Integrated Wellness Acquisition Corp is seeking shareholder approval to extend its deadline for completing a business combination from September 16, 2026, to March 16, 2027, or face potential liquidation.

NexGel, Inc. is convening a special meeting on September 23, 2026, to seek shareholder approval for a significant increase in authorized shares and a potential reverse stock split.

Moleculin Biotech announces its 2026 Annual Meeting of Stockholders, scheduled for October 9, 2026, with key proposals including a reverse stock split, an equity incentive plan amendment, and director elections.